2023-2028 Global and Regional Vendor Neutral Archive (VNA) and PACS Industry Status and Prospects Professional Market Research Report Standard Version
- Category: Business & Services
- Published Date: Mar 2023
- Publisher: HNY Research
- Pages: 169
The global Vendor Neutral Archive (VNA) and PACS market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on Intelligence Market Report newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Agfa Healthcare NV
McKesson Corporation
GE Healthcare
Dell Technologies
Lexmark International
Fujifilm Holdings Corporation
Siemens
Koninklijke Philips NV
IBM Corporation
Novarad Corporation
TeraMedica
Carestream Health
Merge Health
BridgeHead
By Types:
Cloud-hosted
On-Site (Premise)
Hybrid
By Applications:
Enterprise
Cardiology
Radiology
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Agfa Healthcare NV
McKesson Corporation
GE Healthcare
Dell Technologies
Lexmark International
Fujifilm Holdings Corporation
Siemens
Koninklijke Philips NV
IBM Corporation
Novarad Corporation
TeraMedica
Carestream Health
Merge Health
BridgeHead
By Types:
Cloud-hosted
On-Site (Premise)
Hybrid
By Applications:
Enterprise
Cardiology
Radiology
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Vendor Neutral Archive (VNA) and PACS Market Size Analysis from 2023 to 2028
1.5.1 Global Vendor Neutral Archive (VNA) and PACS Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Vendor Neutral Archive (VNA) and PACS Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Vendor Neutral Archive (VNA) and PACS Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Vendor Neutral Archive (VNA) and PACS Industry Impact
Chapter 2 Global Vendor Neutral Archive (VNA) and PACS Competition by Types, Applications, and Top Regions and Countries
2.1 Global Vendor Neutral Archive (VNA) and PACS (Volume and Value) by Type
2.1.1 Global Vendor Neutral Archive (VNA) and PACS Consumption and Market Share by Type (2017-2022)
2.1.2 Global Vendor Neutral Archive (VNA) and PACS Revenue and Market Share by Type (2017-2022)
2.2 Global Vendor Neutral Archive (VNA) and PACS (Volume and Value) by Application
2.2.1 Global Vendor Neutral Archive (VNA) and PACS Consumption and Market Share by Application (2017-2022)
2.2.2 Global Vendor Neutral Archive (VNA) and PACS Revenue and Market Share by Application (2017-2022)
2.3 Global Vendor Neutral Archive (VNA) and PACS (Volume and Value) by Regions
2.3.1 Global Vendor Neutral Archive (VNA) and PACS Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Vendor Neutral Archive (VNA) and PACS Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Vendor Neutral Archive (VNA) and PACS Consumption by Regions (2017-2022)
4.2 North America Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.10 South America Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Vendor Neutral Archive (VNA) and PACS Market Analysis
5.1 North America Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
5.1.1 North America Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
5.2 North America Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
5.3 North America Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
5.4 North America Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
5.4.1 United States Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
5.4.2 Canada Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
5.4.3 Mexico Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 6 East Asia Vendor Neutral Archive (VNA) and PACS Market Analysis
6.1 East Asia Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
6.1.1 East Asia Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
6.2 East Asia Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
6.3 East Asia Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
6.4 East Asia Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
6.4.1 China Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
6.4.2 Japan Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
6.4.3 South Korea Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 7 Europe Vendor Neutral Archive (VNA) and PACS Market Analysis
7.1 Europe Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
7.1.1 Europe Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
7.2 Europe Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
7.3 Europe Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
7.4 Europe Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
7.4.1 Germany Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.2 UK Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.3 France Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.4 Italy Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.5 Russia Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.6 Spain Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.7 Netherlands Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.8 Switzerland Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.9 Poland Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 8 South Asia Vendor Neutral Archive (VNA) and PACS Market Analysis
8.1 South Asia Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
8.1.1 South Asia Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
8.2 South Asia Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
8.3 South Asia Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
8.4 South Asia Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
8.4.1 India Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
8.4.2 Pakistan Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Vendor Neutral Archive (VNA) and PACS Market Analysis
9.1 Southeast Asia Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
9.1.1 Southeast Asia Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
9.2 Southeast Asia Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
9.3 Southeast Asia Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
9.4 Southeast Asia Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
9.4.1 Indonesia Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
9.4.2 Thailand Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
9.4.3 Singapore Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
9.4.4 Malaysia Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
9.4.5 Philippines Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
9.4.6 Vietnam Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
9.4.7 Myanmar Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 10 Middle East Vendor Neutral Archive (VNA) and PACS Market Analysis
10.1 Middle East Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
10.1.1 Middle East Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
10.2 Middle East Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
10.3 Middle East Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
10.4 Middle East Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
10.4.1 Turkey Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.3 Iran Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.5 Israel Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.6 Iraq Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.7 Qatar Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.8 Kuwait Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.9 Oman Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 11 Africa Vendor Neutral Archive (VNA) and PACS Market Analysis
11.1 Africa Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
11.1.1 Africa Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
11.2 Africa Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
11.3 Africa Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
11.4 Africa Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
11.4.1 Nigeria Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
11.4.2 South Africa Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
11.4.3 Egypt Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
11.4.4 Algeria Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
11.4.5 Morocco Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 12 Oceania Vendor Neutral Archive (VNA) and PACS Market Analysis
12.1 Oceania Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
12.2 Oceania Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
12.3 Oceania Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
12.4 Oceania Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
12.4.1 Australia Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
12.4.2 New Zealand Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 13 South America Vendor Neutral Archive (VNA) and PACS Market Analysis
13.1 South America Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
13.1.1 South America Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
13.2 South America Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
13.3 South America Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
13.4 South America Vendor Neutral Archive (VNA) and PACS Consumption Volume by Major Countries
13.4.1 Brazil Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.2 Argentina Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.3 Columbia Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.4 Chile Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.5 Venezuela Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.6 Peru Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.8 Ecuador Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Vendor Neutral Archive (VNA) and PACS Business
14.1 Agfa Healthcare NV
14.1.1 Agfa Healthcare NV Company Profile
14.1.2 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Product Specification
14.1.3 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 McKesson Corporation
14.2.1 McKesson Corporation Company Profile
14.2.2 McKesson Corporation Vendor Neutral Archive (VNA) and PACS Product Specification
14.2.3 McKesson Corporation Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 GE Healthcare
14.3.1 GE Healthcare Company Profile
14.3.2 GE Healthcare Vendor Neutral Archive (VNA) and PACS Product Specification
14.3.3 GE Healthcare Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Dell Technologies
14.4.1 Dell Technologies Company Profile
14.4.2 Dell Technologies Vendor Neutral Archive (VNA) and PACS Product Specification
14.4.3 Dell Technologies Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Lexmark International
14.5.1 Lexmark International Company Profile
14.5.2 Lexmark International Vendor Neutral Archive (VNA) and PACS Product Specification
14.5.3 Lexmark International Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Fujifilm Holdings Corporation
14.6.1 Fujifilm Holdings Corporation Company Profile
14.6.2 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Product Specification
14.6.3 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Siemens
14.7.1 Siemens Company Profile
14.7.2 Siemens Vendor Neutral Archive (VNA) and PACS Product Specification
14.7.3 Siemens Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Koninklijke Philips NV
14.8.1 Koninklijke Philips NV Company Profile
14.8.2 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Product Specification
14.8.3 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 IBM Corporation
14.9.1 IBM Corporation Company Profile
14.9.2 IBM Corporation Vendor Neutral Archive (VNA) and PACS Product Specification
14.9.3 IBM Corporation Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Novarad Corporation
14.10.1 Novarad Corporation Company Profile
14.10.2 Novarad Corporation Vendor Neutral Archive (VNA) and PACS Product Specification
14.10.3 Novarad Corporation Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 TeraMedica
14.11.1 TeraMedica Company Profile
14.11.2 TeraMedica Vendor Neutral Archive (VNA) and PACS Product Specification
14.11.3 TeraMedica Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Carestream Health
14.12.1 Carestream Health Company Profile
14.12.2 Carestream Health Vendor Neutral Archive (VNA) and PACS Product Specification
14.12.3 Carestream Health Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Merge Health
14.13.1 Merge Health Company Profile
14.13.2 Merge Health Vendor Neutral Archive (VNA) and PACS Product Specification
14.13.3 Merge Health Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 BridgeHead
14.14.1 BridgeHead Company Profile
14.14.2 BridgeHead Vendor Neutral Archive (VNA) and PACS Product Specification
14.14.3 BridgeHead Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Vendor Neutral Archive (VNA) and PACS Market Forecast (2023-2028)
15.1 Global Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Vendor Neutral Archive (VNA) and PACS Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Vendor Neutral Archive (VNA) and PACS Value and Growth Rate Forecast (2023-2028)
15.2 Global Vendor Neutral Archive (VNA) and PACS Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Vendor Neutral Archive (VNA) and PACS Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Vendor Neutral Archive (VNA) and PACS Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Vendor Neutral Archive (VNA) and PACS Consumption Forecast by Type (2023-2028)
15.3.2 Global Vendor Neutral Archive (VNA) and PACS Revenue Forecast by Type (2023-2028)
15.3.3 Global Vendor Neutral Archive (VNA) and PACS Price Forecast by Type (2023-2028)
15.4 Global Vendor Neutral Archive (VNA) and PACS Consumption Volume Forecast by Application (2023-2028)
15.5 Vendor Neutral Archive (VNA) and PACS Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Vendor Neutral Archive (VNA) and PACS Market Size Analysis from 2023 to 2028
1.5.1 Global Vendor Neutral Archive (VNA) and PACS Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Vendor Neutral Archive (VNA) and PACS Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Vendor Neutral Archive (VNA) and PACS Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Vendor Neutral Archive (VNA) and PACS Industry Impact
Chapter 2 Global Vendor Neutral Archive (VNA) and PACS Competition by Types, Applications, and Top Regions and Countries
2.1 Global Vendor Neutral Archive (VNA) and PACS (Volume and Value) by Type
2.1.1 Global Vendor Neutral Archive (VNA) and PACS Consumption and Market Share by Type (2017-2022)
2.1.2 Global Vendor Neutral Archive (VNA) and PACS Revenue and Market Share by Type (2017-2022)
2.2 Global Vendor Neutral Archive (VNA) and PACS (Volume and Value) by Application
2.2.1 Global Vendor Neutral Archive (VNA) and PACS Consumption and Market Share by Application (2017-2022)
2.2.2 Global Vendor Neutral Archive (VNA) and PACS Revenue and Market Share by Application (2017-2022)
2.3 Global Vendor Neutral Archive (VNA) and PACS (Volume and Value) by Regions
2.3.1 Global Vendor Neutral Archive (VNA) and PACS Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Vendor Neutral Archive (VNA) and PACS Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Vendor Neutral Archive (VNA) and PACS Consumption by Regions (2017-2022)
4.2 North America Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
4.10 South America Vendor Neutral Archive (VNA) and PACS Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Vendor Neutral Archive (VNA) and PACS Market Analysis
5.1 North America Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
5.1.1 North America Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
5.2 North America Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
5.3 North America Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
5.4 North America Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
5.4.1 United States Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
5.4.2 Canada Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
5.4.3 Mexico Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 6 East Asia Vendor Neutral Archive (VNA) and PACS Market Analysis
6.1 East Asia Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
6.1.1 East Asia Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
6.2 East Asia Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
6.3 East Asia Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
6.4 East Asia Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
6.4.1 China Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
6.4.2 Japan Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
6.4.3 South Korea Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 7 Europe Vendor Neutral Archive (VNA) and PACS Market Analysis
7.1 Europe Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
7.1.1 Europe Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
7.2 Europe Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
7.3 Europe Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
7.4 Europe Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
7.4.1 Germany Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.2 UK Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.3 France Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.4 Italy Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.5 Russia Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.6 Spain Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.7 Netherlands Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.8 Switzerland Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
7.4.9 Poland Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 8 South Asia Vendor Neutral Archive (VNA) and PACS Market Analysis
8.1 South Asia Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
8.1.1 South Asia Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
8.2 South Asia Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
8.3 South Asia Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
8.4 South Asia Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
8.4.1 India Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
8.4.2 Pakistan Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Vendor Neutral Archive (VNA) and PACS Market Analysis
9.1 Southeast Asia Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
9.1.1 Southeast Asia Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
9.2 Southeast Asia Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
9.3 Southeast Asia Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
9.4 Southeast Asia Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
9.4.1 Indonesia Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
9.4.2 Thailand Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
9.4.3 Singapore Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
9.4.4 Malaysia Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
9.4.5 Philippines Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
9.4.6 Vietnam Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
9.4.7 Myanmar Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 10 Middle East Vendor Neutral Archive (VNA) and PACS Market Analysis
10.1 Middle East Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
10.1.1 Middle East Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
10.2 Middle East Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
10.3 Middle East Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
10.4 Middle East Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
10.4.1 Turkey Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.3 Iran Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.5 Israel Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.6 Iraq Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.7 Qatar Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.8 Kuwait Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
10.4.9 Oman Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 11 Africa Vendor Neutral Archive (VNA) and PACS Market Analysis
11.1 Africa Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
11.1.1 Africa Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
11.2 Africa Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
11.3 Africa Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
11.4 Africa Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
11.4.1 Nigeria Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
11.4.2 South Africa Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
11.4.3 Egypt Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
11.4.4 Algeria Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
11.4.5 Morocco Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 12 Oceania Vendor Neutral Archive (VNA) and PACS Market Analysis
12.1 Oceania Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
12.2 Oceania Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
12.3 Oceania Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
12.4 Oceania Vendor Neutral Archive (VNA) and PACS Consumption by Top Countries
12.4.1 Australia Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
12.4.2 New Zealand Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 13 South America Vendor Neutral Archive (VNA) and PACS Market Analysis
13.1 South America Vendor Neutral Archive (VNA) and PACS Consumption and Value Analysis
13.1.1 South America Vendor Neutral Archive (VNA) and PACS Market Under COVID-19
13.2 South America Vendor Neutral Archive (VNA) and PACS Consumption Volume by Types
13.3 South America Vendor Neutral Archive (VNA) and PACS Consumption Structure by Application
13.4 South America Vendor Neutral Archive (VNA) and PACS Consumption Volume by Major Countries
13.4.1 Brazil Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.2 Argentina Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.3 Columbia Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.4 Chile Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.5 Venezuela Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.6 Peru Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
13.4.8 Ecuador Vendor Neutral Archive (VNA) and PACS Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Vendor Neutral Archive (VNA) and PACS Business
14.1 Agfa Healthcare NV
14.1.1 Agfa Healthcare NV Company Profile
14.1.2 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Product Specification
14.1.3 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 McKesson Corporation
14.2.1 McKesson Corporation Company Profile
14.2.2 McKesson Corporation Vendor Neutral Archive (VNA) and PACS Product Specification
14.2.3 McKesson Corporation Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 GE Healthcare
14.3.1 GE Healthcare Company Profile
14.3.2 GE Healthcare Vendor Neutral Archive (VNA) and PACS Product Specification
14.3.3 GE Healthcare Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Dell Technologies
14.4.1 Dell Technologies Company Profile
14.4.2 Dell Technologies Vendor Neutral Archive (VNA) and PACS Product Specification
14.4.3 Dell Technologies Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Lexmark International
14.5.1 Lexmark International Company Profile
14.5.2 Lexmark International Vendor Neutral Archive (VNA) and PACS Product Specification
14.5.3 Lexmark International Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Fujifilm Holdings Corporation
14.6.1 Fujifilm Holdings Corporation Company Profile
14.6.2 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Product Specification
14.6.3 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Siemens
14.7.1 Siemens Company Profile
14.7.2 Siemens Vendor Neutral Archive (VNA) and PACS Product Specification
14.7.3 Siemens Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Koninklijke Philips NV
14.8.1 Koninklijke Philips NV Company Profile
14.8.2 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Product Specification
14.8.3 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 IBM Corporation
14.9.1 IBM Corporation Company Profile
14.9.2 IBM Corporation Vendor Neutral Archive (VNA) and PACS Product Specification
14.9.3 IBM Corporation Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Novarad Corporation
14.10.1 Novarad Corporation Company Profile
14.10.2 Novarad Corporation Vendor Neutral Archive (VNA) and PACS Product Specification
14.10.3 Novarad Corporation Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 TeraMedica
14.11.1 TeraMedica Company Profile
14.11.2 TeraMedica Vendor Neutral Archive (VNA) and PACS Product Specification
14.11.3 TeraMedica Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Carestream Health
14.12.1 Carestream Health Company Profile
14.12.2 Carestream Health Vendor Neutral Archive (VNA) and PACS Product Specification
14.12.3 Carestream Health Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Merge Health
14.13.1 Merge Health Company Profile
14.13.2 Merge Health Vendor Neutral Archive (VNA) and PACS Product Specification
14.13.3 Merge Health Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 BridgeHead
14.14.1 BridgeHead Company Profile
14.14.2 BridgeHead Vendor Neutral Archive (VNA) and PACS Product Specification
14.14.3 BridgeHead Vendor Neutral Archive (VNA) and PACS Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Vendor Neutral Archive (VNA) and PACS Market Forecast (2023-2028)
15.1 Global Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Vendor Neutral Archive (VNA) and PACS Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Vendor Neutral Archive (VNA) and PACS Value and Growth Rate Forecast (2023-2028)
15.2 Global Vendor Neutral Archive (VNA) and PACS Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Vendor Neutral Archive (VNA) and PACS Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Vendor Neutral Archive (VNA) and PACS Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Vendor Neutral Archive (VNA) and PACS Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Vendor Neutral Archive (VNA) and PACS Consumption Forecast by Type (2023-2028)
15.3.2 Global Vendor Neutral Archive (VNA) and PACS Revenue Forecast by Type (2023-2028)
15.3.3 Global Vendor Neutral Archive (VNA) and PACS Price Forecast by Type (2023-2028)
15.4 Global Vendor Neutral Archive (VNA) and PACS Consumption Volume Forecast by Application (2023-2028)
15.5 Vendor Neutral Archive (VNA) and PACS Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
no record found